FindMyKOL
Clinical trialNCT00551759TerminatedPhase 2Interventional

Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer

NCT00551759 is a phase 2 interventional trial sponsored by Eastern Cooperative Oncology Group. As of 21 Nov 2026, it was terminated. It studies Fluorouracil, Cetuximab, Docetaxel and Oxaliplatin in Esophageal Cancer. The registry lists an enrollment of 22 participants at 109 sites in 1 country. The registry lists a start date of 2 Oct 2008 and a primary completion date of 31 Oct 2011.

SponsorEastern Cooperative Oncology GroupEnrollment22Esophageal Cancer
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT00551759
FieldValue
Registry IDNCT00551759
StatusTerminated
PhasePhase 2
Study typeInterventional trial
Lead sponsorEastern Cooperative Oncology Group
Enrollment22
Registered sites109
Countries1
ConditionsEsophageal Cancer
DrugsFluorouracil, Cetuximab, Docetaxel and Oxaliplatin
Start2 Oct 2008
Primary completion31 Oct 2011
Study completion28 Feb 2014
Last update posted3 Jul 2023

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

RATIONALE: Drugs used in chemotherapy, such as oxaliplatin, fluorouracil, and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Radiation therapy uses high-energy x-rays to kill tumor cells. Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. Giving these treatments before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed. Giving docetaxel and cetuximab after surgery may kill any tumor cells that remain after surgery. PURPOSE: This phase II trial is studying how well giving chemotherapy and radiation therapy together with cetuximab followed by surgery, docetaxel and cetuximab works in treating patients with esophageal cancer or gastroesophageal junction cancer.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

109 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Delaware, United States2 sites
  • Tunnell Cancer Center at Beebe Medical Center

    Lewes

  • Ccop - Christiana Care Health Services

    Newark

Illinois, United States15 sites
  • Rush-Copley Cancer Care Center

    Aurora

  • Hematology and Oncology Associates

    Chicago

  • Robert H. Lurie Comprehensive Cancer Center at Northwestern University

    Chicago

  • Decatur Memorial Hospital Cancer Care Institute

    Decatur

  • Hinsdale Hematology Oncology Associates

    Hinsdale

  • Joliet Oncology-Hematology Associates, Limited - West

    Joliet

  • Midwest Center for Hematology/oncology

    Joliet

  • North Shore Oncology and Hematology Associates, Limited - Libertyville

    Libertyville

  • la Grange Oncology Associates - Geneva

    Naperville

  • Cancer Care and Hematology Specialists of Chicagoland - Niles

    Niles

  • Swedish-American Regional Cancer Center

    Rockford

  • Hematology Oncology Associates - Skokie

    Skokie

  • Regional Cancer Center at Memorial Medical Center

    Springfield

  • Ccop - Carle Cancer Center

    Urbana

  • Carle Cancer Center at Carle Foundation Hospital

    Urbana

Indiana, United States1 site
  • Saint Anthony Memorial Health Centers

    Michigan City

Iowa, United States14 sites
  • Mcfarland Clinic, Pc

    Ames

  • Cedar Rapids Oncology Associates

    Cedar Rapids

  • Ccop - Iowa Oncology Research Association

    Des Moines

  • John Stoddard Cancer Center at Iowa Lutheran Hospital

    Des Moines

  • John Stoddard Cancer Center at Iowa Methodist Medical Center

    Des Moines

  • Medical Oncology and Hematology Associates at John Stoddard Cancer Center

    Des Moines

  • Medical Oncology and Hematology Associates at Mercy Cancer Center

    Des Moines

  • Mercy Cancer Center at Mercy Medical Center - Des Moines

    Des Moines

  • Mercy Capitol Hospital

    Des Moines

  • Mercy Cancer Center at Mercy Medical Center - North Iowa

    Mason City

  • Mccreery Cancer Center at Ottumwa Regional

    Ottumwa

  • Mercy Medical Center - Sioux City

    Sioux City

  • Siouxland Hematology-Oncology Associates, Llp

    Sioux City

  • St. Luke's Regional Medical Center

    Sioux City

Kansas, United States19 sites
  • Cancer Center of Kansas, Pa - Chanute

    Chanute

  • Cancer Center of Kansas, Pa - Dodge City

    Dodge City

  • Cancer Center of Kansas, Pa - El Dorado

    El Dorado

  • Cancer Center of Kansas-Independence

    Independence

  • Cancer Center of Kansas, Pa - Kingman

    Kingman

  • Lawrence Memorial Hospital

    Lawrence

  • Southwest Medical Center

    Liberal

  • Cancer Center of Kansas, Pa - Newton

    Newton

  • Cancer Center of Kansas, Pa - Parsons

    Parsons

  • Cancer Center of Kansas, Pa - Pratt

    Pratt

  • Cancer Center of Kansas, Pa - Salina

    Salina

  • Cancer Center of Kansas, Pa - Wellington

    Wellington

  • Associates in Womens Health, Pa - North Review

    Wichita

  • Ccop - Wichita

    Wichita

  • Cancer Center of Kansas, Pa - Medical Arts Tower

    Wichita

  • Cancer Center of Kansas, Pa - Wichita

    Wichita

  • Via Christi Cancer Center at Via Christi Regional Medical Center

    Wichita

  • Wesley Medical Center

    Wichita

  • Cancer Center of Kansas, Pa - Winfield

    Winfield

Maryland, United States2 sites
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    Baltimore

  • Union Hospital Cancer Program at Union Hospital

    Elkton

Massachusetts, United States1 site
  • Beth Israel Deaconess Medical Center

    Boston

Michigan, United States3 sites
  • Borgess Medical Center

    Kalamazoo

  • Bronson Methodist Hospital

    Kalamazoo

  • West Michigan Cancer Center

    Kalamazoo

Minnesota, United States13 sites
  • Fairview Ridges Hospital

    Burnsville

  • Mercy and Unity Cancer Center at Mercy Hospital

    Coon Rapids

  • Fairview Southdale Hospital

    Edina

  • Mercy and Unity Cancer Center at Unity Hospital

    Fridley

  • Minnesota Oncology Hematology, Pa - Maplewood

    Maplewood

  • Virginia Piper Cancer Institute at Abbott - Northwestern Hospital

    Minneapolis

  • Hubert H. Humphrey Cancer Center at North Memorial Outpatient Center

    Robbinsdale

  • Ccop - Metro-Minnesota

    Saint Louis Park

  • Park Nicollet Cancer Center

    Saint Louis Park

  • United Hospital

    Saint Paul

  • St. Francis Cancer Center at St. Francis Medical Center

    Shakopee

  • Ridgeview Medical Center

    Waconia

  • Minnesota Oncology Hematology, Pa - Woodbury

    Woodbury

Nebraska, United States5 sites
  • Cancer Resource Center - Lincoln

    Lincoln

  • Alegant Health Cancer Center at Bergan Mercy Medical Center

    Omaha

  • Ccop - Missouri Valley Cancer Consortium

    Omaha

  • Creighton University Medical Center

    Omaha

  • Immanuel Medical Center

    Omaha

New Jersey, United States5 sites
  • Fox Chase Virtua Health Cancer Program at Virtua Memorial Hospital Marlton

    Marlton

  • Carol G. Simon Cancer Center at Morristown Memorial Hospital

    Morristown

  • Overlook Hospital

    Summit

  • Cancer Institute of New Jersey at Cooper - Voorhees

    Voorhees Township

  • Fox Chase Virtua Health Cancer Program at Virtua West Jersey

    Voorhees Township

New York, United States1 site
  • Our Lady of Mercy Medical Center Comprehensive Cancer Center

    The Bronx

Ohio, United States3 sites
  • Summa Center for Cancer Care at Akron City Hospital

    Akron

  • Aultman Cancer Center at Aultman Hospital

    Canton

  • Mercy Cancer Center at Mercy Medical Center

    Canton

Pennsylvania, United States10 sites
  • St. Luke's Cancer Network at St. Luke's Hospital

    Bethlehem

  • Bryn Mawr Hospital

    Bryn Mawr

  • Cancer Center of Paoli Memorial Hospital

    Paoli

  • Kimmel Cancer Center at Thomas Jefferson University - Philadelphia

    Philadelphia

  • Upmc Cancer Centers

    Pittsburgh

  • Pottstown Memorial Regional Cancer Center

    Pottstown

  • Mcglinn Family Regional Cancer Center at Reading Hospital and Medical Center

    Reading

  • Hematology and Oncology Associates of Northeastern Pennsylvania

    Scranton

  • Ccop - Main Line Health

    Wynnewood

  • Lankenau Cancer Center at Lankenau Hospital

    Wynnewood

South Dakota, United States3 sites
  • Avera Cancer Institute

    Sioux Falls

  • Medical X-Ray Center, Pc

    Sioux Falls

  • Sanford Cancer Center at Sanford Usd Medical Center

    Sioux Falls

Wisconsin, United States12 sites
  • Center for Cancer Treatment & Prevention at Sacred Heart Hospital

    Eau Claire

  • Marshfield Clinic Cancer Care at Regional Cancer Center

    Eau Claire

  • Gundersen Lutheran Center for Cancer and Blood

    La Crosse

  • Marshfield Clinic - Marshfield Center

    Marshfield

  • Saint Joseph's Hospital

    Marshfield

  • Marshfield Clinic - Lakeland Center

    Minocqua

  • Ministry Medical Group at Saint Mary's Hospital

    Rhinelander

  • Marshfield Clinic - Indianhead Center

    Rice Lake

  • Saint Michael's Hospital Cancer Center

    Stevens Point

  • Marshfield Clinic - Wausau Center

    Wausau

  • Marshfield Clinic - Weston Center

    Weston

  • Marshfield Clinic - Wisconsin Rapids Center

    Wisconsin Rapids

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesota: 13 sitesMN13Wisconsin: 12 sitesWI12Michigan: 3 sitesMI3New York: 1 siteNY1Massachusetts: 1 siteMA1Rhode IslandRIOregonORIdahoIDSouth Dakota: 3 sitesSD3Iowa: 14 sitesIA14Illinois: 15 sitesIL15Indiana: 1 siteIN1Ohio: 3 sitesOH3Pennsylvania: 10 sitesPA10New Jersey: 5 sitesNJ5ConnecticutCTCaliforniaCANevadaNVWyomingWYNebraska: 5 sitesNE5MissouriMOKentuckyKYWest VirginiaWVVirginiaVAMaryland: 2 sitesMD2Delaware: 2 sitesDE2ArizonaAZUtahUTColoradoCOKansas: 19 sitesKS19ArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Questions about NCT00551759

Each answer restates registry values shown on this page.

What is NCT00551759?

NCT00551759 is a phase 2 interventional trial sponsored by Eastern Cooperative Oncology Group. It studies Fluorouracil, Cetuximab, Docetaxel and Oxaliplatin in Esophageal Cancer.

Who leads NCT00551759?

The registry names Michael K. Gibson, MD (study chair, University of Pittsburgh) as the overall official.

Where does NCT00551759 run?

The registry lists 109 sites in 1 country. Every site with a stated country is in one country: United States.

Which drugs does NCT00551759 study?

The registered drug and biological interventions are Fluorouracil, Cetuximab, Docetaxel and Oxaliplatin.

When did NCT00551759 end?

The registry lists a primary completion date of 31 Oct 2011 and a study completion date of 28 Feb 2014. The sponsor last updated the record on 3 Jul 2023.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.